KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Other Non-Current Liabilities: 2009-2025

Historic Other Non-Current Liabilities for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $57.6 million.

  • Idexx Laboratories' Other Non-Current Liabilities fell 8.36% to $57.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.6 million, marking a year-over-year decrease of 8.36%. This contributed to the annual value of $44.3 million for FY2024, which is 32.33% down from last year.
  • Latest data reveals that Idexx Laboratories reported Other Non-Current Liabilities of $57.6 million as of Q3 2025, which was up 1.47% from $56.8 million recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Other Non-Current Liabilities peaked at $85.0 million during Q2 2021, and registered a low of $44.3 million during Q4 2024.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $60.2 million (2023), whereas its average is $59.1 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first crashed by 32.33% in 2024, then climbed by 6.35% in 2025.
  • Idexx Laboratories' Other Non-Current Liabilities (Quarterly) stood at $70.9 million in 2021, then fell by 4.73% to $67.6 million in 2022, then fell by 3.05% to $65.5 million in 2023, then tumbled by 32.33% to $44.3 million in 2024, then decreased by 8.36% to $57.6 million in 2025.
  • Its last three reported values are $57.6 million in Q3 2025, $56.8 million for Q2 2025, and $47.7 million during Q1 2025.